Top Markets
Coin of the day
Kyto Technology and Life Science, Inc. Kyto Technology and Life Science, Inc.

Kyto Technology and Life Science, Inc.

KBPH
Classifica tra le azioni #34729
Kyto Technology and Life Science, Inc. operates as a venture capital firm,... Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors. The firm's funding approach offers two main options: either secured convertible debt (which accrues interest and includes a conversion discount into preferred equity) or direct investment in preferred shares. Notably, Kyto Technology and Life Science does not take the lead role in financing rounds. Its investment capital is geographically distributed, with half allocated to ventures in the United States and the remainder supporting companies in Canada and Israel. Established in 1999, the company was formerly known as Kyto BioPharma, Inc. before rebranding in April 2018. It maintains its headquarters in Los Altos Hills, California, with a secondary office located in Scotts Valley, California.
Prezzo delle azioni
$1.00
Ultima sincronizzazione: 2023-05-23
Capitalizzazione di mercato
$5.03M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Kyto Technology and Life Science, Inc. (KBPH)
Utile per Kyto Technology and Life Science, Inc. (KBPH)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Kyto Technology and Life Science, Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Kyto Technology and Life Science, Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$9.17B -
US
$8.07B -
US
- -
SE
$6.24B -
US
$3.70B -
US